Literature DB >> 32236734

Successful treatment of intracranial Rosai-Dorfman disease with cytarabine and dexamethasone: case report and review of literature.

Wei Wang1, Jian Sun2, Wei Zhang3, Daobin Zhou1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32236734     DOI： 10.1007/s00277-020-03999-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

Review 1.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity.

Authors:  E Foucar; J Rosai; R Dorfman
Journal:  Semin Diagn Pathol       Date:  1990-02       Impact factor: 3.464

2.  Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.

Authors:  Valentina Arnao; Marianna Riolo; Giovanni Savettieri; Paolo Aridon
Journal:  Case Rep Neurol Med       Date:  2016-10-20
  2 in total
  3 in total

1.  Rosai-Dorfman-Destombes disease: isolated intracranial without nodal involvement presentation. Illustrative case.

Authors:  César Chong; Xavier Wong-Achi; Cinthya Apolo
Journal:  J Neurosurg Case Lessons       Date:  2021-06-14

2.  Staging surgery for intraventricular bilateral giant Rosai-Dorfman disease in children.

Authors:  Jiyin Zhang; Dapeng Li; Ran Cheng; Nan Zhang; Xin Ni; Ming Ge
Journal:  Pediatr Investig       Date:  2022-03-07

3.  Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.

Authors:  Ting Liu; Hua-Cong Cai; Hao Cai; Miao Chen; Wei Zhang; Jian Li; Dao-Bin Zhou; Xin-Xin Cao
Journal:  Orphanet J Rare Dis       Date:  2022-02-07       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.